Pint Pharma specializes in enabling access to novel therapies in rare disease and specialty care communities by developing a direct/indirect relationship with the various stakeholders in the health system, from diagnosis to medication, for the ultimate benefit of the patients
Company operates in 7 countries in Latin America (LatAm) including all key markets: Brazil, Colombia, Argentina and Mexico
Community-centric platform developed by the company allows for an easily scalable operation in the fields of hematology and rare genetic disorders, amongst others
Key highlights
Expansive regional platform
More than
500M
people
More than
30M
patients
Our Investors
Farallon Capital Management, L.L.C.® is a global institutional asset management firm founded in 1986, with approximately 180 employees and whose AUMs as of today amount to 25 billion dollars. The firm is headquartered in San Francisco and has offices in London, Singapore, Hong Kong, Tokyo, and São Paulo.
Farallon places a priority on the preservation of capital. While the firm values and employs risk management analytics, it primarily manages risk through rigorous research and analysis. Faralon also seeks to build strong relationships with the management of the companies in which it invest.